Auxiliary splice factor U2AF26 and transcription factor Gfi1 cooperate directly in regulating CD45 alternative...

Area of Science:

• Immunology
• Molecular Biology
• Gene Regulation

Background:

• Alternative splicing of the CD45 gene generates isoforms that modulate T cell receptor (TCR) signaling.
• CD45 isoforms, such as CD45RB (more active) and CD45RO (less active), play critical roles in T cell function.
• Understanding the regulation of CD45 alternative splicing is crucial for controlling T cell activation.

Purpose of the Study:

• To investigate the regulatory mechanisms governing CD45 alternative splicing.
• To identify key factors involved in controlling the balance between CD45RB and CD45RO isoform production.
• To elucidate the functional consequences of this regulation on T cell signaling.

Main Methods:

• Analysis of CD45 alternative splicing patterns.
• Investigated the roles of splicing factor U2AF26 and transcription factor Gfi1.
• Studied the interaction between U2AF26 and Gfi1 using molecular biology techniques.

Main Results:

• U2AF26 promotes the production of the less active CD45RO isoform by facilitating exon exclusion.
• Gfi1 antagonizes U2AF26 activity through direct interaction, promoting the more active CD45RB isoform.
• Loss of Gfi1 leads to increased CD45RO production, while its presence favors CD45RB.

Conclusions:

• CD45 alternative splicing is cooperatively regulated by U2AF26 and Gfi1.
• A novel link between a transcription factor (Gfi1) and alternative splicing machinery (U2AF26) is identified.
• The relative abundance of U2AF26 and Gfi1 dictates the CD45 isoform ratio, thereby controlling T cell activation.